Thalassemia carrier screening and prenatal diagnosis among the British Columbia (Canada) population of Chinese descent

Authors: Yong, Karina N1; Wadsworth, Louis D2; Langlois, Sylvie3; Yong, Siu Li3; Wilson, R Douglas

Source: Clinical Genetics, Volume 55, Number 1, January 1999 , pp. 20-25(6)

Publisher: Blackwell Publishing

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

The goal of thalassemia screening is the identification, prior to the conception or birth of an affected child, of couples where both partners are thalassemia carriers. When both partners are identified as carriers for alpha- or beta-thalassemia, the risk of having a fetus who is homozygous or compound heterozygous for the abnormal gene is 25%. A study was performed to identify whether routine screening for thalassemia is indicated for the Chinese population in British Columbia (BC). In a population of 783 subjects, studied either prospectively or retrospectively, 5.0% were alpha-thalassemia carriers and 1.7% were beta-thalassemia carriers.In addition, a review of all BC cases of prenatal diagnosis for thalassemia over a 6-year period indicated that 26% of couples were identified as alpha-thalassemia carriers because of a second or third trimester diagnosis of fetal hydrops, and 17% of couples referred for beta-thalassemia already had an affected child. The experience with prenatal diagnosis shows that a significant proportion of at-risk couples are not identified prior to or early in a pregnancy. The prevalence of carriers for thalassemia would warrant a program of education and routine screening for this condition in the BC Asian population.

Keywords: prenatal diagnosis; screening; thalassemia

Document Type: Research article

DOI: 10.1034/j.1399-0004.1999.550104.x

Affiliations: 1: Department of Obstetrics and Gynecology, British Columbia Children's and Women's Hospital, Vancouver, British Columbia, Canada 2: Department of Hematopathology/Transfusion Medicine, 3: Department of Medical Genetics,

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$50.39 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A